After Record Growth in 2022, Etiometry Paves Way for 2023 Expansion
BOSTON , January 31 /Businesswire/ - “Our regulatory success uniquely positions Etiometry for further developments in 2023 that will result in enhanced offerings benefiting patients and the care teams treating them,” said Shane Cooke, CEO of Etiometry.